Pub Date : 2024-10-30DOI: 10.1021/acssynbio.4c0041610.1021/acssynbio.4c00416
Yi-Lei Zheng, Ye Xu, Yan-Qiu Liu, Qing-Wei Zhao and Yong-Quan Li*,
Bakuchiol (BAK), a specialized meroterpene, is known for its valuable biological properties and has recently gained prominence in cosmetology for its retinol-like functionality. However, low abundance in natural sources leads to environmentally unfriendly and unsustainable practices associated with crop-based manufacturing and chemical synthesis. Here, we identified a prenyltransferase (PT) from Psoralea corylifolia that catalyzes the reverse geranylation of a nonaromatic carbon in para-coumaric acid (p-CA), coupled with a decarboxylation step to form BAK. Given that the biosynthesis pathway of BAK is well elucidated, we engineered Saccharomyces cerevisiae to produce BAK, starting from glucose. To enhance the titer of BAK, we employed a multifaceted approach that included increasing the supply of precursors, balancing the fluxes in the two parallel biosynthetic pathways, engineering of prenyltransferase, and fusing enzymes. Consequently, the engineered yeast strains showed a marked improvement of 117.3-fold in BAK production, reaching a titer of 9.28 mg/L from glucose. Our work provides a viable approach for the sustainable microbial production of complex natural meroterpenes.
巴克烯二醇(BAK)是一种特殊的经萜烯类化合物,因其宝贵的生物特性而闻名,最近又因其类似视黄醇的功能而在美容领域大放异彩。然而,由于天然来源的丰度较低,导致以农作物为基础的生产和化学合成方法对环境不友好且不可持续。在这里,我们从茜草中发现了一种前酰基转移酶(PT),它能催化对位香豆酸(p-CA)中一个非芳香族碳的反向香叶酯化作用,并通过脱羧步骤形成 BAK。鉴于 BAK 的生物合成途径已被充分阐明,我们改造了酿酒酵母,使其从葡萄糖开始生产 BAK。为了提高 BAK 的滴度,我们采用了一种多方面的方法,包括增加前体的供应、平衡两条平行生物合成途径的通量、前酰转移酶的工程化以及酶的融合。结果,工程酵母菌株的 BAK 产量明显提高了 117.3 倍,葡萄糖滴度达到 9.28 毫克/升。我们的工作为复杂天然美拉德萜烯的可持续微生物生产提供了一种可行的方法。
{"title":"De Novo Biosynthesis of a Bioactive Meroterpene Bakuchiol in Yeast","authors":"Yi-Lei Zheng, Ye Xu, Yan-Qiu Liu, Qing-Wei Zhao and Yong-Quan Li*, ","doi":"10.1021/acssynbio.4c0041610.1021/acssynbio.4c00416","DOIUrl":"https://doi.org/10.1021/acssynbio.4c00416https://doi.org/10.1021/acssynbio.4c00416","url":null,"abstract":"<p >Bakuchiol (BAK), a specialized meroterpene, is known for its valuable biological properties and has recently gained prominence in cosmetology for its retinol-like functionality. However, low abundance in natural sources leads to environmentally unfriendly and unsustainable practices associated with crop-based manufacturing and chemical synthesis. Here, we identified a prenyltransferase (PT) from <i>Psoralea corylifolia</i> that catalyzes the reverse geranylation of a nonaromatic carbon in <i>para</i>-coumaric acid (<i>p</i>-CA), coupled with a decarboxylation step to form BAK. Given that the biosynthesis pathway of BAK is well elucidated, we engineered <i>Saccharomyces cerevisiae</i> to produce BAK, starting from glucose. To enhance the titer of BAK, we employed a multifaceted approach that included increasing the supply of precursors, balancing the fluxes in the two parallel biosynthetic pathways, engineering of prenyltransferase, and fusing enzymes. Consequently, the engineered yeast strains showed a marked improvement of 117.3-fold in BAK production, reaching a titer of 9.28 mg/L from glucose. Our work provides a viable approach for the sustainable microbial production of complex natural meroterpenes.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"13 11","pages":"3600–3608 3600–3608"},"PeriodicalIF":3.7,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-30DOI: 10.1021/acssynbio.4c0045510.1021/acssynbio.4c00455
Alexa F. Van Voorhis, and , Rebecca S. Sherbo*,
Xanthobacter autotrophicus is a metabolically flexible microorganism with two key features: (1) The organism has adapted to grow on a wide variety of carbon sources including CO2, methanol, formate, propylene, haloalkanes and haloacids; and (2) X. autotrophicus was the first chemoautotroph identified that could also simultaneously fix N2, meaning the organism can utilize CO2, N2, and H2 for growth. This metabolic flexibility has enabled use of X. autotrophicus for gas fixation, the creation of fertilizers and foods from gases, and the dehalogenation of environmental contaminants. Despite the wide variety of applications that have already been demonstrated for this organism, there are few genetic tools available to explore and exploit its metabolism. Here, we report a genetic toolbox for use in X. autotrophicus. We first identified suitable origins of replication and quantified their copy number, and identified antibiotic resistance cassettes that could be used as selectable markers. We then tested several constitutive and inducible promoters and terminators and quantified their promoter strengths and termination efficiencies. Finally, we demonstrated that gene expression tools remain effective under both autotrophic and dehalogenative metabolic conditions to show that these tools can be used in the environments that make X. autotrophicus unique. Our extensive characterization of these tools in X. autotrophicus will enable genetic and metabolic engineering to optimize production of fertilizers and foods from gases, and enable bioremediation of halogenated environmental contaminants.
{"title":"Creating a Genetic Toolbox for the Carbon-Fixing, Nitrogen-Fixing and Dehalogenating Bacterium Xanthobacter autotrophicus","authors":"Alexa F. Van Voorhis, and , Rebecca S. Sherbo*, ","doi":"10.1021/acssynbio.4c0045510.1021/acssynbio.4c00455","DOIUrl":"https://doi.org/10.1021/acssynbio.4c00455https://doi.org/10.1021/acssynbio.4c00455","url":null,"abstract":"<p ><i>Xanthobacter autotrophicus</i> is a metabolically flexible microorganism with two key features: (1) The organism has adapted to grow on a wide variety of carbon sources including CO<sub>2</sub>, methanol, formate, propylene, haloalkanes and haloacids; and (2) <i>X. autotrophicus</i> was the first chemoautotroph identified that could also simultaneously fix N<sub>2</sub>, meaning the organism can utilize CO<sub>2</sub>, N<sub>2</sub>, and H<sub>2</sub> for growth. This metabolic flexibility has enabled use of <i>X. autotrophicus</i> for gas fixation, the creation of fertilizers and foods from gases, and the dehalogenation of environmental contaminants. Despite the wide variety of applications that have already been demonstrated for this organism, there are few genetic tools available to explore and exploit its metabolism. Here, we report a genetic toolbox for use in <i>X. autotrophicus</i>. We first identified suitable origins of replication and quantified their copy number, and identified antibiotic resistance cassettes that could be used as selectable markers. We then tested several constitutive and inducible promoters and terminators and quantified their promoter strengths and termination efficiencies. Finally, we demonstrated that gene expression tools remain effective under both autotrophic and dehalogenative metabolic conditions to show that these tools can be used in the environments that make <i>X. autotrophicus</i> unique. Our extensive characterization of these tools in <i>X. autotrophicus</i> will enable genetic and metabolic engineering to optimize production of fertilizers and foods from gases, and enable bioremediation of halogenated environmental contaminants.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"13 11","pages":"3658–3667 3658–3667"},"PeriodicalIF":3.7,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acssynbio.4c00455","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.1021/acssynbio.4c0056010.1021/acssynbio.4c00560
Krishna Madduri*, Deepa Acharya, Adam Lescallette, Jeremy McFadden, Paul Ketterer, Jade Bing and Babu Raman,
We report the successful cell-free reconstitution of two natural product biosynthetic pathways of divergent complexity and structural classes. We first constructed the teleocidin biosynthetic pathway using our BY-2 (tobacco) cell-free protein synthesis (CFPS) system. We discovered a direct interaction between TleA and MbtH, and showed that the BY-2 system is capable of producing more than 80 mg/L teleocidin B-3 with cofactor supplementation and ∼20 mg/L with no cofactors supplemented, demonstrating the high metabolic activity of the system. We then extended our methodology and report the first successful cell-free biosynthesis of UK-2 diol (precursor to the commercially valuable secondary metabolite UK-2A) from simple building blocks by refactoring a complex pathway of 10 proteins in the wheat germ CFPS system. We show that plant CFPS systems are suitable for reconstructing pathways and identifying the functions of uncharacterized genes linked to biosynthetic gene clusters and rate-limiting biosynthetic steps.
{"title":"Application of a Cell-Free Synthetic Biology Platform for the Reconstitution of Teleocidin B and UK-2A Precursor Biosynthetic Pathways","authors":"Krishna Madduri*, Deepa Acharya, Adam Lescallette, Jeremy McFadden, Paul Ketterer, Jade Bing and Babu Raman, ","doi":"10.1021/acssynbio.4c0056010.1021/acssynbio.4c00560","DOIUrl":"https://doi.org/10.1021/acssynbio.4c00560https://doi.org/10.1021/acssynbio.4c00560","url":null,"abstract":"<p >We report the successful cell-free reconstitution of two natural product biosynthetic pathways of divergent complexity and structural classes. We first constructed the teleocidin biosynthetic pathway using our BY-2 (tobacco) cell-free protein synthesis (CFPS) system. We discovered a direct interaction between TleA and MbtH, and showed that the BY-2 system is capable of producing more than 80 mg/L teleocidin B-3 with cofactor supplementation and ∼20 mg/L with no cofactors supplemented, demonstrating the high metabolic activity of the system. We then extended our methodology and report the first successful cell-free biosynthesis of UK-2 diol (precursor to the commercially valuable secondary metabolite UK-2A) from simple building blocks by refactoring a complex pathway of 10 proteins in the wheat germ CFPS system. We show that plant CFPS systems are suitable for reconstructing pathways and identifying the functions of uncharacterized genes linked to biosynthetic gene clusters and rate-limiting biosynthetic steps.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"13 11","pages":"3711–3723 3711–3723"},"PeriodicalIF":3.7,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142641074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.1021/acssynbio.4c0037610.1021/acssynbio.4c00376
Sheng Wang*, Xueming Wu, Zhenghao Qiao, Xuan He, Yu Li, Tianyu Zhang, Weiwei Liu, Ming Wang, Xiangtian Zhou* and Yang Yu*,
Implementing dynamic control over gene transcription to decouple cell growth is essential for regulating protein expression in microbial cells. However, the availability of efficient regulatory elements in Saccharomyces cerevisiae remains limited. In this study, we present a novel β-estradiol-inducible gene expression system, termed DEN. This system combines a DNA-binding domain with an estradiol-binding domain and an intrinsically disordered region (IDR) from NUP98. Comparative analysis shows that the DEN system outperforms IDRs from other proteins, achieving an approximately 60-fold increase in EGFP expression upon β-estradiol induction. Moreover, our system is tightly controlled; nontoxic gene expression makes it a powerful tool for rapid and precise modulation of target gene expression. This system holds great potential for unlocking new functionalities from existing proteins in future research.
对基因转录实施动态控制,使细胞生长脱钩,对于调节微生物细胞中蛋白质的表达至关重要。然而,在酿酒酵母中可用的高效调控元件仍然有限。在这项研究中,我们提出了一种新型的β-雌二醇诱导基因表达系统,称为DEN。该系统结合了 DNA 结合域、雌二醇结合域和来自 NUP98 的内在无序区(IDR)。比较分析表明,DEN 系统优于其他蛋白质的 IDR,在β-雌二醇诱导下,EGFP 的表达量增加了约 60 倍。此外,我们的系统是严格控制的;无毒基因表达使其成为快速、精确调节靶基因表达的有力工具。在未来的研究中,该系统具有从现有蛋白质中释放新功能的巨大潜力。
{"title":"Systematic Evaluation and Application of IDR Domain-Mediated Transcriptional Activation of NUP98 in Saccharomyces cerevisiae","authors":"Sheng Wang*, Xueming Wu, Zhenghao Qiao, Xuan He, Yu Li, Tianyu Zhang, Weiwei Liu, Ming Wang, Xiangtian Zhou* and Yang Yu*, ","doi":"10.1021/acssynbio.4c0037610.1021/acssynbio.4c00376","DOIUrl":"https://doi.org/10.1021/acssynbio.4c00376https://doi.org/10.1021/acssynbio.4c00376","url":null,"abstract":"<p >Implementing dynamic control over gene transcription to decouple cell growth is essential for regulating protein expression in microbial cells. However, the availability of efficient regulatory elements in <i>Saccharomyces cerevisiae</i> remains limited. In this study, we present a novel β-estradiol-inducible gene expression system, termed DEN. This system combines a DNA-binding domain with an estradiol-binding domain and an intrinsically disordered region (IDR) from NUP98. Comparative analysis shows that the DEN system outperforms IDRs from other proteins, achieving an approximately 60-fold increase in EGFP expression upon β-estradiol induction. Moreover, our system is tightly controlled; nontoxic gene expression makes it a powerful tool for rapid and precise modulation of target gene expression. This system holds great potential for unlocking new functionalities from existing proteins in future research.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"13 11","pages":"3765–3773 3765–3773"},"PeriodicalIF":3.7,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142641075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Low sensitivity, photobleaching, high-power excitation and long acquisition times constrain the utility of afterglow luminescence. Here we report the design and imaging performance of nanoparticles made of electron-rich trianthracene derivatives that, on excitation by room light at ultralow power (58 μW cm–2), emit afterglow luminescence at ~500 times those of commonly used organic afterglow nanoparticles. The nanoparticles’ ultrabright afterglow allowed for deep-tissue imaging (up to 6 cm), for ultrafast afterglow imaging (at short acquisition times down to 0.01 s) of naturally behaving mice with negligible photobleaching, even after re-excitation for over 15 cycles, and for the accurate visualization of subcutaneous and orthotopic tumours and of plaque in carotid arteries. We also show that an afterglow nanoparticle that is activated only in the presence of granzyme B allowed for the tracking of granzyme-B activity in the context of therapeutic monitoring. The high sensitivity and negligible photobleaching of the organic afterglow nanoparticles offer advantages for real-time in vivo monitoring of physiopathological processes.
灵敏度低、光漂白、高功率激发和较长的采集时间限制了余辉发光的实用性。在这里,我们报告了富电子蒽衍生物纳米粒子的设计和成像性能,这种纳米粒子在超低功率(58 μW cm-2)室光激发下发出的余辉是常用有机余辉纳米粒子的约 500 倍。这种纳米粒子的超亮余辉可用于深部组织成像(长达 6 厘米)、自然行为小鼠的超快余辉成像(短至 0.01 秒的采集时间),即使在重新激发超过 15 个周期后,光漂白现象也可忽略不计,还可用于皮下肿瘤、原位肿瘤和颈动脉斑块的精确成像。我们还展示了一种仅在颗粒酶 B 存在时才被激活的余辉纳米粒子,它可以在治疗监测中跟踪颗粒酶 B 的活性。有机余辉纳米粒子的高灵敏度和可忽略不计的光漂白为实时监测体内生理病理过程提供了优势。
{"title":"Ultrabright and ultrafast afterglow imaging in vivo via nanoparticles made of trianthracene derivatives","authors":"Youjuan Wang, Jing Guo, Muchao Chen, Shiyi Liao, Li Xu, Qian Chen, Guosheng Song, Xiao-Bing Zhang","doi":"10.1038/s41551-024-01274-8","DOIUrl":"https://doi.org/10.1038/s41551-024-01274-8","url":null,"abstract":"<p>Low sensitivity, photobleaching, high-power excitation and long acquisition times constrain the utility of afterglow luminescence. Here we report the design and imaging performance of nanoparticles made of electron-rich trianthracene derivatives that, on excitation by room light at ultralow power (58 μW cm<sup>–2</sup>), emit afterglow luminescence at ~500 times those of commonly used organic afterglow nanoparticles. The nanoparticles’ ultrabright afterglow allowed for deep-tissue imaging (up to 6 cm), for ultrafast afterglow imaging (at short acquisition times down to 0.01 s) of naturally behaving mice with negligible photobleaching, even after re-excitation for over 15 cycles, and for the accurate visualization of subcutaneous and orthotopic tumours and of plaque in carotid arteries. We also show that an afterglow nanoparticle that is activated only in the presence of granzyme B allowed for the tracking of granzyme-B activity in the context of therapeutic monitoring. The high sensitivity and negligible photobleaching of the organic afterglow nanoparticles offer advantages for real-time in vivo monitoring of physiopathological processes.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"71 1","pages":""},"PeriodicalIF":28.1,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142519963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.1016/j.jhep.2024.10.028
Zhujun Cao, Yujing Yao, Minghao Cai, Chenxi Zhang, Yuhan Liu, Haiguang Xin, Baoyan An, Hui Wang, Yide Lu, Ziqiang Li, Yaoxing Chen, Yan Huang, Min Xin, Ruokun Li, Zhuping Qian, Yi Zhou, Xiaogang Xiang, Richard Moreau, Qing Xie
Background and aims
In patients with acutely decompensated cirrhosis (ADC) who present with clinically apparent precipitants (i.e., infections, acute liver injury), alterations in blood markers of inflammation associate with progression toward severe phenotypes (e.g., acute-on-chronic liver failure, ACLF). It is unclear whether alterations in blood inflammatory markers may associate with progression of ADC independently of precipitants.
Methods
We prospectively enrolled 394 patients admitted for ADC who were classified into four phenotypes of increasing severity: no organ dysfunction (n=168), organ dysfunction alone (n=72), organ failure without ACLF (n=91), and ACLF (n=63). Clinical blood cell counts and serum levels of inflammatory markers (including soluble markers related to type-1, type-2, and type-3 inflammation) were obtained at enrollment. Ordinal regression with adjacent categories logit model adjusted for confounders (including precipitants) was used to analyze associations between changes in each blood inflammatory marker and the worsening of ADC.
Results
Inflammatory markers that were associated with higher risk of progressing to the next more severe stage were as follows: increasing neutrophil counts (adjusted common odds ratio [cOR] 1.17, 95%CI 1.06-1.28); increasing levels of the type-2 cytokine interleukin (IL)-25 (cOR 1.21, 95%CI 1.06-1.39), type-3 cytokines IL-6 (cOR 1.15, 95%CI 1.02-1.28) and IL-22 (cOR 1.16, 95%CI 1.03-1.30), or anti-inflammatory soluble CD163 (cOR 1.94, 95%CI 1.58-2.38); decreasing lymphocyte counts (cOR 0.77, 95%CI 0.68-0.87), or decreasing levels of the type-1 cytokine IFN-γ (cOR 0.85, 95%CI 0.75-0.95).
Conclusions
Among patients with ADC, alterations in blood levels of cytokines related to type-1, type-2 and type-3 inflammation, together with neutrophilia, lymphopenia and elevated anti-inflammatory signals were individually associated with an increased risk of progressing toward ACLF, independently of the presence of clinically apparent precipitants.
{"title":"Blood markers for type-1,-2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis","authors":"Zhujun Cao, Yujing Yao, Minghao Cai, Chenxi Zhang, Yuhan Liu, Haiguang Xin, Baoyan An, Hui Wang, Yide Lu, Ziqiang Li, Yaoxing Chen, Yan Huang, Min Xin, Ruokun Li, Zhuping Qian, Yi Zhou, Xiaogang Xiang, Richard Moreau, Qing Xie","doi":"10.1016/j.jhep.2024.10.028","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.028","url":null,"abstract":"<h3>Background and aims</h3>In patients with acutely decompensated cirrhosis (ADC) who present with clinically apparent precipitants (i.e., infections, acute liver injury), alterations in blood markers of inflammation associate with progression toward severe phenotypes (e.g., acute-on-chronic liver failure, ACLF). It is unclear whether alterations in blood inflammatory markers may associate with progression of ADC independently of precipitants.<h3>Methods</h3>We prospectively enrolled 394 patients admitted for ADC who were classified into four phenotypes of increasing severity: no organ dysfunction (n=168), organ dysfunction alone (n=72), organ failure without ACLF (n=91), and ACLF (n=63). Clinical blood cell counts and serum levels of inflammatory markers (including soluble markers related to type-1, type-2, and type-3 inflammation) were obtained at enrollment. Ordinal regression with adjacent categories logit model adjusted for confounders (including precipitants) was used to analyze associations between changes in each blood inflammatory marker and the worsening of ADC.<h3>Results</h3>Inflammatory markers that were associated with higher risk of progressing to the next more severe stage were as follows: increasing neutrophil counts (adjusted common odds ratio [cOR] 1.17, 95%CI 1.06-1.28); increasing levels of the type-2 cytokine interleukin (IL)-25 (cOR 1.21, 95%CI 1.06-1.39), type-3 cytokines IL-6 (cOR 1.15, 95%CI 1.02-1.28) and IL-22 (cOR 1.16, 95%CI 1.03-1.30), or anti-inflammatory soluble CD163 (cOR 1.94, 95%CI 1.58-2.38); decreasing lymphocyte counts (cOR 0.77, 95%CI 0.68-0.87), or decreasing levels of the type-1 cytokine IFN-γ (cOR 0.85, 95%CI 0.75-0.95).<h3>Conclusions</h3>Among patients with ADC, alterations in blood levels of cytokines related to type-1, type-2 and type-3 inflammation, together with neutrophilia, lymphopenia and elevated anti-inflammatory signals were individually associated with an increased risk of progressing toward ACLF, independently of the presence of clinically apparent precipitants.","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"25 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142536590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.1038/s41551-024-01262-y
Xiao Wang, Youkui Huang, Ling-Ling Chen
Optimized methods for the synthesis of circular RNA in vitro and in cells, and a complementary Cas9 de-immunization method, enhance RNA persistence and reduce immunogenicity for applications in genome engineering and cell engineering.
{"title":"Expanded toolkits for RNA circularization","authors":"Xiao Wang, Youkui Huang, Ling-Ling Chen","doi":"10.1038/s41551-024-01262-y","DOIUrl":"https://doi.org/10.1038/s41551-024-01262-y","url":null,"abstract":"Optimized methods for the synthesis of circular RNA in vitro and in cells, and a complementary Cas9 de-immunization method, enhance RNA persistence and reduce immunogenicity for applications in genome engineering and cell engineering.","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"23 1","pages":""},"PeriodicalIF":28.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142519259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.1016/j.progpolymsci.2024.101900
Antonio Rizzo , Gregory I. Peterson
The ball-mill grinding (BMG) of polymers has a long history, starting with Staudinger showing in the 1930s that polystyrene undergoes chain scission upon ball milling. However, BMG has significantly expanded from being used solely for polymer degradation to a synthetic tool for a range of applications only in the last decade. Now, BMG has emerged as a promising mechanochemistry technique for several critically important polymer technologies, such as recycling and upcycling, and often provides novel or enhanced mechanochemical reactivity. As a solid-state technique in which solvents are often minimized or eliminated, BMG provides a greener and more sustainable route to various applications. Also, in contrast to many other mechanochemistry techniques that are commonly employed with polymers, BMG has the potential to be scaled to industrially relevant levels. In our review, we provide an extended and deep overview of the phenomena that occur when polymers are subjected to BMG and show how these phenomena can be exploited for various applications. We treat particularly technologies that, especially in the context of our current plastic pollution crisis, are relevant to trending topics in the field of polymer science, such as polymer degradation, chemical recycling, recycling, and upcycling. Other important topics covered in this review include the mechanical activation of responsive polymers, by the use of mechanophores or by exploiting the reactivity of the reactive intermediates generated during chain scission, and polymer-assisted grinding, where polymers serve as additives or reagents to aid in mechanochemical syntheses or other processes.
{"title":"Progress toward sustainable polymer technologies with ball-mill grinding","authors":"Antonio Rizzo , Gregory I. Peterson","doi":"10.1016/j.progpolymsci.2024.101900","DOIUrl":"10.1016/j.progpolymsci.2024.101900","url":null,"abstract":"<div><div>The ball-mill grinding (BMG) of polymers has a long history, starting with Staudinger showing in the 1930s that polystyrene undergoes chain scission upon ball milling. However, BMG has significantly expanded from being used solely for polymer degradation to a synthetic tool for a range of applications only in the last decade. Now, BMG has emerged as a promising mechanochemistry technique for several critically important polymer technologies, such as recycling and upcycling, and often provides novel or enhanced mechanochemical reactivity. As a solid-state technique in which solvents are often minimized or eliminated, BMG provides a greener and more sustainable route to various applications. Also, in contrast to many other mechanochemistry techniques that are commonly employed with polymers, BMG has the potential to be scaled to industrially relevant levels. In our review, we provide an extended and deep overview of the phenomena that occur when polymers are subjected to BMG and show how these phenomena can be exploited for various applications. We treat particularly technologies that, especially in the context of our current plastic pollution crisis, are relevant to trending topics in the field of polymer science, such as polymer degradation, chemical recycling, recycling, and upcycling. Other important topics covered in this review include the mechanical activation of responsive polymers, by the use of mechanophores or by exploiting the reactivity of the reactive intermediates generated during chain scission, and polymer-assisted grinding, where polymers serve as additives or reagents to aid in mechanochemical syntheses or other processes.</div></div>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"159 ","pages":"Article 101900"},"PeriodicalIF":26.0,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142520012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-26DOI: 10.1016/j.jhep.2024.10.032
Zgjim Osmani, Willem Pieter Brouwer, Dwin G.B. Grashof, Youkyung Lim, Michael Doukas, Harry L.A. Janssen, Harmen J.G. van de Werken, Andre Boonstra
<h3>Background & Aims</h3>Chronic HBV patients with concomitant metabolic dysfunction-associated steatohepatitis (MASH) have been shown to develop more advanced fibrosis faster with more severe liver disease as compared to patients with chronic HBV alone. However, our understanding of the underlying mechanisms is limited. Here we study how MASH co-morbidity impact immune activity in the liver of patients with chronic HBV infection.<h3>Methods</h3>Bulk RNA sequencing was performed on liver biopsies from patients with only MASH (n=10), only HBeAg-negative chronic HBV (ENEG; n=11), combined MASH/ENEG (n=9) and healthy controls (n=9). Biopsies with no or minimal fibrosis (≤F2) were selected to avoid confounding effects of fibrosis. We compared whole transcriptome data from patients with MASH/ENEG to those with ENEG alone to determine the impact of MASH co-morbidity on chronic hepatitis B.<h3>Results</h3>There is a high degree of overlap of liver gene expression profiles in patients with only ENEG versus those with only MASH compared to healthy controls, suggesting a largely shared mechanism of liver dysfunction and immune activity for these distinct conditions. In patients with ENEG, MASH co-morbidity significantly reduced interferon pathway activity (NES=2.03, p.adj=0.0251), the expression of ISGs (e.g., <em>IFIT2</em>, <em>IFI27</em>, <em>IFITM1</em>, <em>IFI6</em>), and macrophage gene signatures (e.g., <em>MARCO</em>, <em>CD163</em>, <em>CD5L</em>, <em>CD63</em>), when compared to patients with ENEG alone.<h3>Conclusions</h3>Transcriptomic profiling of the liver suggests that MASH negatively impacts ISGs expression in the liver of patients with ENEG, which may affect antiviral immune pathways, viral replication and inflammatory responses resulting in an increased risk of advanced fibrosis in patients with chronic hepatitis B. Our study provides valuable insights for guiding future research aimed at developing effective, tailored strategies for managing patients with both conditions.<h3>Impact and implications</h3>In recent decades, obesity and associated health issues have reached epidemic levels, with steatotic liver disease affecting up to 30% of adults in developed countries, and this trend is also observed among chronic hepatitis B patients. Given the high and rising prevalence of steatotic liver disease and its frequent co-occurrence in chronic hepatitis B patients, it is essential to understand how conditions such as metabolic dysfunction-associated steatohepatitis (MASH) impact immune responses in the liver. This study provides unique insights into the impact of MASH on HBV antiviral immune activity in the liver of patients with chronic hepatitis B. The rising number of patients with both conditions affects treatment outcomes and highlights the urgent need for novel, tailored therapeutic strategies. Our study holds significant relevance for guiding future research on developing treatment strategies for patients with both MASH and chron
{"title":"Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis B","authors":"Zgjim Osmani, Willem Pieter Brouwer, Dwin G.B. Grashof, Youkyung Lim, Michael Doukas, Harry L.A. Janssen, Harmen J.G. van de Werken, Andre Boonstra","doi":"10.1016/j.jhep.2024.10.032","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.032","url":null,"abstract":"<h3>Background & Aims</h3>Chronic HBV patients with concomitant metabolic dysfunction-associated steatohepatitis (MASH) have been shown to develop more advanced fibrosis faster with more severe liver disease as compared to patients with chronic HBV alone. However, our understanding of the underlying mechanisms is limited. Here we study how MASH co-morbidity impact immune activity in the liver of patients with chronic HBV infection.<h3>Methods</h3>Bulk RNA sequencing was performed on liver biopsies from patients with only MASH (n=10), only HBeAg-negative chronic HBV (ENEG; n=11), combined MASH/ENEG (n=9) and healthy controls (n=9). Biopsies with no or minimal fibrosis (≤F2) were selected to avoid confounding effects of fibrosis. We compared whole transcriptome data from patients with MASH/ENEG to those with ENEG alone to determine the impact of MASH co-morbidity on chronic hepatitis B.<h3>Results</h3>There is a high degree of overlap of liver gene expression profiles in patients with only ENEG versus those with only MASH compared to healthy controls, suggesting a largely shared mechanism of liver dysfunction and immune activity for these distinct conditions. In patients with ENEG, MASH co-morbidity significantly reduced interferon pathway activity (NES=2.03, p.adj=0.0251), the expression of ISGs (e.g., <em>IFIT2</em>, <em>IFI27</em>, <em>IFITM1</em>, <em>IFI6</em>), and macrophage gene signatures (e.g., <em>MARCO</em>, <em>CD163</em>, <em>CD5L</em>, <em>CD63</em>), when compared to patients with ENEG alone.<h3>Conclusions</h3>Transcriptomic profiling of the liver suggests that MASH negatively impacts ISGs expression in the liver of patients with ENEG, which may affect antiviral immune pathways, viral replication and inflammatory responses resulting in an increased risk of advanced fibrosis in patients with chronic hepatitis B. Our study provides valuable insights for guiding future research aimed at developing effective, tailored strategies for managing patients with both conditions.<h3>Impact and implications</h3>In recent decades, obesity and associated health issues have reached epidemic levels, with steatotic liver disease affecting up to 30% of adults in developed countries, and this trend is also observed among chronic hepatitis B patients. Given the high and rising prevalence of steatotic liver disease and its frequent co-occurrence in chronic hepatitis B patients, it is essential to understand how conditions such as metabolic dysfunction-associated steatohepatitis (MASH) impact immune responses in the liver. This study provides unique insights into the impact of MASH on HBV antiviral immune activity in the liver of patients with chronic hepatitis B. The rising number of patients with both conditions affects treatment outcomes and highlights the urgent need for novel, tailored therapeutic strategies. Our study holds significant relevance for guiding future research on developing treatment strategies for patients with both MASH and chron","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"35 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142519458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-25DOI: 10.1007/s41114-024-00052-x
Marcelo Disconzi
We review some recent developments in mathematical aspects of relativistic fluids. The goal is to provide a quick entry point to some research topics of current interest that is accessible to graduate students and researchers from adjacent fields, as well as to researches working on broader aspects of relativistic fluid dynamics interested in its mathematical formalism. Instead of complete proofs, which can be found in the published literature, here we focus on the proofs’ main ideas and key concepts. After an introduction to the relativistic Euler equations, we cover the following topics: a new wave-transport formulation of the relativistic Euler equations tailored to applications; the problem of shock formation for relativistic Euler; rough (i.e., low-regularity) solutions to the relativistic Euler equations; the relativistic Euler equations with a physical vacuum boundary; relativistic fluids with viscosity. We finish with a discussion of open problems and future directions of research.
{"title":"Recent developments in mathematical aspects of relativistic fluids","authors":"Marcelo Disconzi","doi":"10.1007/s41114-024-00052-x","DOIUrl":"10.1007/s41114-024-00052-x","url":null,"abstract":"<div><p>We review some recent developments in mathematical aspects of relativistic fluids. The goal is to provide a quick entry point to some research topics of current interest that is accessible to graduate students and researchers from adjacent fields, as well as to researches working on broader aspects of relativistic fluid dynamics interested in its mathematical formalism. Instead of complete proofs, which can be found in the published literature, here we focus on the proofs’ main ideas and key concepts. After an introduction to the relativistic Euler equations, we cover the following topics: a new wave-transport formulation of the relativistic Euler equations tailored to applications; the problem of shock formation for relativistic Euler; rough (i.e., low-regularity) solutions to the relativistic Euler equations; the relativistic Euler equations with a physical vacuum boundary; relativistic fluids with viscosity. We finish with a discussion of open problems and future directions of research.</p></div>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"27 1","pages":""},"PeriodicalIF":26.3,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s41114-024-00052-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}